Annual report pursuant to Section 13 and 15(d)

Note 1 - Nature of Operations and Summary of Significant Accounting Policies (Tables)

v3.7.0.1
Note 1 - Nature of Operations and Summary of Significant Accounting Policies (Tables)
12 Months Ended
Dec. 31, 2016
Notes Tables  
Schedule of Franchisor Disclosure [Table Text Block]
    Year Ended
 December 31,
Franchised clinics:   2016   2015
Clinics in operation at beginning of period    
265
     
242
 
Opened during the period    
56
     
54
 
Acquired during the period    
(6
)    
(24
)
Closed during the period    
(6
)    
(7
)
Clinics in operation at the end of the period    
309
     
265
 
    Year Ended
 December 31,
Company-owned or managed clinics:   2016   2015
Clinics in operation at beginning of period    
47
     
4
 
Opened during the period    
8
     
21
 
Acquired during the period    
6
     
24
 
Closed during the period    
-
     
(2
)
Clinics in operation at the end of the period    
61
     
47
 
                 
Total clinics in operation at the end of the period    
370
     
312
 
                 
Clinic licenses sold but not yet developed    
115
     
168
 
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
    Year Ended
 December 31,
    2016   2015
         
Net loss   $
(15,173,872
)   $
(8,797,321
)
                 
Weighted average common shares outstanding - basic    
12,696,649
     
10,042,001
 
Effect of dilutive securities:                
Stock options    
-
     
-
 
Weighted average common shares outstanding - diluted    
12,696,649
     
10,042,001
 
                 
Basic and diluted loss per share   $
(1.20
)   $
(0.88
)
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]
    Year Ended
 December 31,
    2016   2015
Unvested restricted stock    
92,415
     
339,288
 
Stock options    
953,075
     
477,459
 
Warrants    
90,000
     
90,000